- Home
- THAR vs AIRS Comparison
THAR vs AIRS Comparison
Compare THAR & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | THAR | AIRS |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.3M | 166.3M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | THAR | AIRS |
|---|---|---|
| Price | $4.64 | $2.17 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 1.2M | ★ 1.9M |
| Earning Date | 11-12-2025 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $157,554,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $1.53 |
| 52 Week High | $9.08 | $12.00 |
Technical Indicators
Market Signals| Indicator | THAR | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 64.60 | 37.91 |
| Support Level | $2.71 | $2.69 |
| Resistance Level | $5.83 | $3.07 |
| Average True Range (ATR) | 0.50 | 0.38 |
| MACD | 0.20 | 0.00 |
| Stochastic Oscillator | 60.74 | 5.56 |
Price Performance
Historical ComparisonAbout THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.